FRPRF Projected Dividend Yield
4D Pharma PLC ( OTCBB : FRPRF )4D pharma is engaged in the development of drug ? Live Biotherapeutic products utilizing the profound impact of the gut microbiome on human health and disease. Co.'s technologies include Live Biotherapeutics, and MicroRx®. Co.'s Live Biotherapeutics are single strains of human gut-derived commensal bacteria. Co.'s drug candidates are taxonomically diverse and exhibit distinct mechanisms relevant to specific aspects of disease pathology. Co.'s MicroRx® combines techniques across microbiology, immunology and bioinformatics to characterise and interrogate its library of bacterial isolates. Co.'s library represents phylogenetic coverage of the genera of the human gut microbiome. 20 YEAR PERFORMANCE RESULTS |
FRPRF Dividend History Detail FRPRF Dividend News FRPRF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |